Advances in Molecular Diagnosis of HBV Infection and Drug Resistance

Sablon, Erwin; Shapiro, Fred

doi:10.7150/ijms.2.8



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2005; 2(1):8-16. doi:10.7150/ijms.2.8 This issue Cite

Review

Advances in Molecular Diagnosis of HBV Infection and Drug Resistance

Erwin Sablon, Fred Shapiro

Innogenetics NV, Industriepark Zwijnaarde, Belgium

Citation:

Sablon E, Shapiro F. Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. Int J Med Sci 2005; 2(1):8-16. doi:10.7150/ijms.2.8. https://www.medsci.org/v02p0008.htm

Other styles

Abstract

Serological markers are key elements in diagnosing acute hepatitis B virus (HBV) infection and determining its possible evolution towards chronicity. Once treatment of chronic HBV is initiated with approved anti-hepadnaviral agents, such as lamivudine, interferon-alpha, or adefovir dipivoxil, the measurement of HBV DNA in serum can not only help monitor treatment efficacy but also indicates breakthrough infection should drug resistance emerge. Advances in the molecular diagnosis of drug resistance using highly sensitive methodologies such as DNA hybridization assays can further pinpoint the type of mutation responsible and, more importantly, detect upcoming viral resistance at an early stage when the variant represents only a minor fraction of the total viral population. Such new tools are especially relevant for patients at high risk for disease progression or acute exacerbation. Recent diagnostic developments including HBV genotyping and precore/core promoter assays that could well play important future roles in HBV patient management are also reviewed.

Keywords: Molecular Diagnosis, HBV Infection, Drug Resistance

Citation styles

APA

Sablon, E., Shapiro, F. (2005). Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. International Journal of Medical Sciences, 2(1), 8-16. https://doi.org/10.7150/ijms.2.8.

ACS

Sablon, E.; Shapiro, F. Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. Int. J. Med. Sci. 2005, 2 (1), 8-16. DOI: 10.7150/ijms.2.8.

NLM

Sablon E, Shapiro F. Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. Int J Med Sci 2005; 2(1):8-16. doi:10.7150/ijms.2.8. https://www.medsci.org/v02p0008.htm

CSE

Sablon E, Shapiro F. 2005. Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. Int J Med Sci. 2(1):8-16.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.